Sort
21,453 grants matching “tuberculosis”
Conduct Synthesis and Acquire Batches of Compounds for Subsequent Biological In Vitro and In Vivo Testing
$1,245,214Mark Middleton · Starks Associates, Inc. · N01 · FY2023 · AI
Genetic Disorder of Mucocilary Clearance
$1,244,846Michael R Knowles · Univ Of North Carolina Chapel Hill · U54 · FY2017 · HL
Vaccine and Treatment Evaluation Units
$1,244,414Nadine Georges Rouphael · Emory University · UM1 · FY2023 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,243,702Kathryn Hafford · Virginia State Dept Of Health · U52 · FY2009 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,243,702Kathryn Hafford · Virginia State Dept Of Health · U52 · FY2008 · PS
Genetic Disorder of Mucocilary Clearance
$1,242,974Michael R Knowles · Univ Of North Carolina Chapel Hill · U54 · FY2016 · HL
University of Rochester Vaccine and Treatment Evaluation Unit(VTEU)-DMID 21-0012
$1,242,949Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI
Innate inflammatory responses during pulmonary infections
$1,242,800Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
International Epi Databases to Evaluate AIDS (IEDEA) in central Africa (Region 9)
$1,242,247Tyler D Hartwell · Research Triangle Institute · U01 · FY2007 · AI
Genes/Pathways for Autophagy-dependent inhibition of Bacterial Infections
$1,242,024Ramnik J Xavier · Washington University · U19 · FY2015 · AI
ADULT AIDS CLINICAL TRIAL UNIT
$1,241,833University Of Texas Medical Br Galveston · U01 · FY2004 · AI
The Asia-Pacific HIV Observational Database (APHOD)
$1,240,736David A Cooper · Foundation For Aids Research · U01 · FY2008 · AI
Inhaled Large Porous Particles for Treatment of MDR-TB
$1,237,893Harvard University · U01 · FY2004 · AI
Center for Clinical and Translational Sciences (CCTS)
$1,237,762David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2021 · TR
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
$1,237,628Christopher C. Whalen · Case Western Reserve University · R01 · FY2006 · AI
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages
$1,236,573Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$1,235,184Myron E Essex · Harvard School Of Public Health · UM1 · FY2015 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM
$1,234,282Nancy Baruch · Maryland State Department Of Health · U52 · FY2012 · PS
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$1,233,499Shea S Rabley · South Carolina Department Of Public Health · U52 · FY2008 · PS
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$1,232,598University Of Texas Sw Med Ctr/Dallas · U01 · FY2002 · AI
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$1,232,521Clifton Barry · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma
$1,231,164Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2025 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$1,230,515Pablo Tebas · University Of Pennsylvania · UM1 · FY2016 · AI
Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment
$1,229,745C Robert Horsburgh · Boston University Medical Campus · U01 · FY2016 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,227,954University Of Pittsburgh At Pittsburgh · U01 · FY2001 · AI